Nystatin Cream USP, (100,000 USP Nystatin Units), NET WT 15 g, Rx only, 15 g tube, Manufactured by Padagis, Yeruham, Israel, NDC 45802-059-35
Published July 22, 2026 · Recall initiated: June 23, 2026
Summary
FDA records drug Class II recall D-0677-2026, published July 22, 2026 and initiated June 23, 2026. Recalling firm: Padagis US LLC; Status: Ongoing; Reported quantity: 180,936 tubes; Lot: Lot #: 205060, Exp 09/30/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug: Low out of specification assay results performed during long-term stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email if NYSTATIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- NYSTATIN
- Manufacturer
- Padagis US LLC
- Distributor
- USA Nationwide
- Lot
- Lot #: 205060, Exp 09/30/2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACVS Health, Carbamide Peroxide, 6.5%, 0.5 FL Oz (15 mL), a) Bottle (NDC 51316-822-00.); b) Kit (1 BULB,July 22, 2026
- FDABrand Name: Versius Surgical System US Product Name: Vesius Surgeon Console US Model/Catalog Number: V-SS-1020July 15, 2026
- FDANystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, Rx ONLY, packaged in a) 16 fl ozAugust 18, 2021
- FDANystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl. oz. (473 mL), Rx only,August 19, 2020
- FDANystatin Oral Suspension, USP, 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl oz (473 mL) bottle, RxApril 1, 2020
- FDANystatin Oral Suspension, USP 100,000 units per mL Cherry/Peppermint Flavor, 16 fl oz (473 mL) Rx Only, pai,February 5, 2020
Questions about this recall
Was Nystatin Cream USP, (100,000 USP Nystatin Units), NET WT 15 g, Rx only, 15 g tube, Manufactured by Padagis, Yeruham, Israel, NDC 45802-059-35 recalled?
Yes. FDA published recall D-0677-2026 on July 22, 2026. Reported hazard: Subpotent Drug: Low out of specification assay results performed during long-term stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: NYSTATIN.